HEADER    SUGAR BINDING PROTEIN                   03-FEB-23   8G21              
TITLE     REELIN C-TERMINAL REGION                                              
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: REELIN;                                                    
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: C-TERMINAL RESIDUES 3429-3460;                             
COMPND   5 EC: 3.4.21.-;                                                        
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: RELN;                                                          
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 EXPRESSION_SYSTEM_VECTOR: PET28A                                     
KEYWDS    ALZHEIMERS DISEASE, GAG INTERACTION, SUGAR BINDING PROTEIN            
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    A.S.CHANDRAHAS,C.MARINO,J.F.ARBOLEDA-VELASQUEZ                        
REVDAT   3   15-MAY-24 8G21    1       REMARK                                   
REVDAT   2   07-JUN-23 8G21    1       AUTHOR JRNL                              
REVDAT   1   31-MAY-23 8G21    0                                                
JRNL        AUTH   F.LOPERA,C.MARINO,A.S.CHANDRAHAS,M.O'HARE,                   
JRNL        AUTH 2 N.D.VILLALBA-MORENO,D.AGUILLON,A.BAENA,J.S.SANCHEZ,          
JRNL        AUTH 3 C.VILA-CASTELAR,L.RAMIREZ GOMEZ,N.CHMIELEWSKA,G.M.OLIVEIRA,  
JRNL        AUTH 4 J.L.LITTAU,K.HARTMANN,K.PARK,S.KRASEMANN,M.GLATZEL,          
JRNL        AUTH 5 D.SCHOEMAKER,L.GONZALEZ-BUENDIA,S.DELGADO-TIRADO,            
JRNL        AUTH 6 S.AREVALO-ALQUICHIRE,K.L.SAEZ-TORRES,D.AMARNANI,L.A.KIM,     
JRNL        AUTH 7 R.C.MAZZARINO,H.GORDON,Y.BOCANEGRA,A.VILLEGAS,X.GAI,         
JRNL        AUTH 8 M.BOOTWALLA,J.JI,L.SHEN,K.S.KOSIK,Y.SU,Y.CHEN,A.SCHULTZ,     
JRNL        AUTH 9 R.A.SPERLING,K.JOHNSON,E.M.REIMAN,D.SEPULVEDA-FALLA,         
JRNL        AUTH10 J.F.ARBOLEDA-VELASQUEZ,Y.T.QUIROZ                            
JRNL        TITL   RESILIENCE TO AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE IN A    
JRNL        TITL 2 REELIN-COLBOS HETEROZYGOUS MAN.                              
JRNL        REF    NAT MED                       V.  29  1243 2023              
JRNL        REFN                   ISSN 1546-170X                               
JRNL        PMID   37188781                                                     
JRNL        DOI    10.1038/S41591-023-02318-3                                   
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.2.1                                            
REMARK   3   AUTHORS     : BRUNGER A. T. ET.AL.                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: 20 BEST STRUCTURES SUPERIMPOSED ON        
REMARK   3  BACKBONE ATOMS (N,CA,C,O)                                           
REMARK   4                                                                      
REMARK   4 8G21 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-23.                  
REMARK 100 THE DEPOSITION ID IS D_1000272047.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298.15                             
REMARK 210  PH                             : 7.4                                
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : NULL                               
REMARK 210  SAMPLE CONTENTS                : 3.3 MM [U-98% 15N] REELIN CTR,     
REMARK 210  50 % V/V THF (CF3-CD2-OH), 0.25 MM DSS (4,4-DIMETHYL-4-             
REMARK 210  SILAPENTANE-1-SULFONIC ACID), 50% H2O/50% D2O                       
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 1H TOCSY; 1H NOESY; 2D 1H-15N;     
REMARK 210                                   2D 1H-13C                          
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ                            
REMARK 210  SPECTROMETER MODEL             : DIRECT DRIVE                       
REMARK 210  SPECTROMETER MANUFACTURER      : AGILENT                            
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : ARIA 2.3.2, PSVS, CCPNMR           
REMARK 210                                   ANALYSIS 2.4.2, NMRPIPE, PYMOL     
REMARK 210                                   2.5.4, CNS 1.2.1                   
REMARK 210   METHOD USED                   : NA                                 
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 20                                 
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 ARG A  30      115.37   -162.03                                   
REMARK 500  2 TYR A  31      134.86     70.57                                   
REMARK 500  3 TYR A  31      138.43     69.89                                   
REMARK 500  4 TYR A  31      151.44     73.63                                   
REMARK 500  8 ARG A  30       39.77    -89.17                                   
REMARK 500  9 TYR A  31      145.88     74.15                                   
REMARK 500 12 ARG A  30       53.17    -90.35                                   
REMARK 500 13 ARG A  30       80.41     54.41                                   
REMARK 500 15 TYR A  31      132.27     70.53                                   
REMARK 500 16 ARG A  30       81.23     57.27                                   
REMARK 500 18 TYR A  31      134.88     77.98                                   
REMARK 500 19 ARG A  30     -155.64   -117.11                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 31073   RELATED DB: BMRB                                 
REMARK 900 REELIN C-TERMINAL REGION                                             
DBREF  8G21 A    1    32  UNP    P78509   RELN_HUMAN    3429   3460             
SEQRES   1 A   32  SER THR ARG LYS GLN ASN TYR MET MET ASN PHE SER ARG          
SEQRES   2 A   32  GLN HIS GLY LEU ARG HIS PHE TYR ASN ARG ARG ARG ARG          
SEQRES   3 A   32  SER LEU ARG ARG TYR PRO                                      
HELIX    1 AA1 THR A    2  ARG A   30  1                                  29    
CISPEP   1 TYR A   31    PRO A   32          1        -1.32                     
CISPEP   2 TYR A   31    PRO A   32          2        -0.67                     
CISPEP   3 TYR A   31    PRO A   32          3        -3.11                     
CISPEP   4 TYR A   31    PRO A   32          4        -2.60                     
CISPEP   5 TYR A   31    PRO A   32          5        -2.12                     
CISPEP   6 TYR A   31    PRO A   32          6        -2.30                     
CISPEP   7 TYR A   31    PRO A   32          7        -2.71                     
CISPEP   8 TYR A   31    PRO A   32          8       -10.35                     
CISPEP   9 TYR A   31    PRO A   32          9        -6.09                     
CISPEP  10 TYR A   31    PRO A   32         10        -1.72                     
CISPEP  11 TYR A   31    PRO A   32         11        -5.64                     
CISPEP  12 TYR A   31    PRO A   32         12         0.16                     
CISPEP  13 TYR A   31    PRO A   32         13        -2.55                     
CISPEP  14 TYR A   31    PRO A   32         14        -0.06                     
CISPEP  15 TYR A   31    PRO A   32         15        -1.04                     
CISPEP  16 TYR A   31    PRO A   32         16        -2.79                     
CISPEP  17 TYR A   31    PRO A   32         17        -0.73                     
CISPEP  18 TYR A   31    PRO A   32         18        -0.07                     
CISPEP  19 TYR A   31    PRO A   32         19        -4.74                     
CISPEP  20 TYR A   31    PRO A   32         20        -1.58                     
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
